← Leaderboards
Mary K. Katherine Howett
Pennsylvania State Univ Hershey Med Ctr
$116,434
Attributed
$116,434
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,862,679 · 4
By mechanism
P01$3,862,679 · 4
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Lisa S Poritz$620,730
- John W. Wills$7,883,830
- Neil D Christensen$4,364,737
- Priscilla B. Wyrick$3,614,778
- Daniel Malamud$17,592,139
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationAntiviral AgentsMicroorganism Disease ChemotherapySexually Transmitted DiseasesDisease /Disorder ModelHuman TissueLaboratory MouseXenotransplantationTopical Drug ApplicationVaginaAntibacterial AgentsClinical ResearchHuman PapillomavirusHerpes Simplex Virus 2EpitheliumVirus Infection MechanismProgesteroneAthymic MouseChlamydia TrachomatisEstrogensHormone Regulation /Control MechanismHuman Fetus TissueHuman Immunodeficiency VirusKeratinocyte
Grant awards (15)
MICROBICIDES IN MODEL SYSTEMS$1,030,856
P01 · FY2003 · AI
MICROBICIDES IN MODEL SYSTEMS$944,931
P01 · FY2002 · AI
IN VIVO MODELS FOR HUMAN GENITAL TISSUES AND SEXUALLY TRANSMITTED DISEASES$0
P01 · FY2002 · AI
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT$0
P01 · FY2002 · AI
BLOCKING HIV INFECTION OF VAGINAL XENOGRAPHS$0
P01 · FY2002 · HD
MICROBICIDES IN MODEL SYSTEMS$975,635
P01 · FY2001 · AI
MICROBICIDES IN MODEL SYSTEMS$82,803
P01 · FY2001 · AI
IN VIVO MODELS FOR HUMAN GENITAL TISSUES AND SEXUALLY TRANSMITTED DISEASES$0
P01 · FY2001 · AI
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT$0
P01 · FY2001 · AI
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT$0
P01 · FY2001 · AI
IN VIVO MODELS FOR HUMAN GENITAL TISSUES AND SEXUALLY TRANSMITTED DISEASES$0
P01 · FY2001 · AI
BLOCKING HIV INFECTION OF VAGINAL XENOGRAPHS$0
P01 · FY2001 · HD
MICROBICIDES IN MODEL SYSTEMS$712,020
P01 · FY2000 · AI
IN VIVO MODELS FOR HUMAN GENITAL TISSUES AND SEXUALLY TRANSMITTED DISEASES$58,217
P01 · FY2000 · AI
TOPICAL THERAPY FOR HSV-2 INFECTION OF THE GENITAL TRACT$58,217
P01 · FY2000 · AI